EMGLIF M 12.5/1000MG TAB

EMGLIF M combines empagliflozin and metformin HCl in a single tablet for effective type 2 diabetes management. Empagliflozin works by increasing glucose excretion through urine, while metformin reduces hepatic glucose production and improves insulin sensitivity. This dual-action formulation helps regulate blood sugar levels and may support cardiovascular health. Each tablet contains 12.5mg empagliflozin and 1000mg metformin HCl. Suitable for adults with type 2 diabetes when diet and exercise alone are insufficient. Always follow your healthcare provider's dosage instructions and monitor blood glucose regularly.